Aethlon Medical to Present at 12th International Conference on Dialysis

SAN DIEGO, Jan. 19  /PRNewswire-FirstCall/ -- Aethlon Medical, Inc. (OTC Bulletin Board: AEMD) announced today that its Chief Science Officer, Dr. Richard H. Tullis, will give a clinical presentation of the Aethlon Hemopurifier® at the 12th International Conference on Dialysis on January 22nd.  The presentation will review treatment outcomes of dialysis patients infected with Hepatitis-C (HCV), and will discuss the additional use of the Hemopurifier® in HIV and Cancer care.  The conference will be held at the Marriott New Orleans in New Orleans, Louisiana.  Additional information, including the speaker agenda, can be accessed online at: http://www.renalresearch.com/.

  (Logo:  http://www.newscom.com/cgi-bin/prnh/20090325/LA88762LOGO-b)

  About Aethlon Medical


Aethlon Medical creates diagnostic and therapeutic device solutions for infectious disease and cancer. Our Hemopurifier® represents the first-in-class medical device to selectively adsorb viruses and immunosuppressive toxins from the bloodstream. The Hemopurifier® seeks to improve Hepatitis-C treatment outcomes and serves as a broad-spectrum treatment countermeasure against bioterror and pandemic threats. Additional information regarding Aethlon Medical can be accessed online at http://www.aethlonmedical.com/.

  Contacts:

  RedChip Companies, Inc.
  Jon Cunningham
  1-800-733-2447, Ext. 107
  

  Jim Joyce
  Chairman, CEO
  858.459.7800 x301
  

  Jim Frakes
  Senior VP Finance
  858.459.7800 x300
  

http://www.newscom.com/cgi-bin/prnh/20090325/LA88762LOGO-b

http://photoarchive.ap.org/

DATASOURCE: Aethlon Medical, Inc.



CONTACT:  CONTACT:  Jon Cunningham of RedChip Companies, Inc.,

1-800-733-2447, ext. 107, , for Aethlon Medical, Inc.; or Jim

Joyce, Chairman, CEO, [phone], ext. 301, , or Jim

Frakes, Senior VP Finance, [phone], ext. 300,

, both of Aethlon Medical, Inc.



Web Site:  http://www.aethlonmedical.com/

http://www.renalresearch.com/ 

Copyright